DUNN JOHN MICHAEL

Track

Insider profile

Performance

Overall performance
2.3
Performance over holding periods
2.3
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 92% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
DUNN JOHN MICHAEL's trades of Acer Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
53.18
Quantity 58,380 -28.9%
Value US$1,011,230
US Biogen Inc (BIIB)
Transaction date
Sale
Price
384.11
Quantity 92,492 +48.4%
Value US$1,806,792
US Biogen Inc (BIIB)
Transaction date
Sale
Price
316.70
Quantity 18,509 +41.8%
Value US$4,476,272
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-07-28 2020-07-24
B Purchase
58,380 -28.9%
53.18
US$1,011,230 		58,380 -28.9% 53.18 US$1,011,230
2004-05-19 2004-05-18
US Biogen Inc (BIIB)
S Sale
92,492 +48.4%
384.11
US$1,806,792 		92,492 +48.4% 384.11 US$1,806,792
2004-05-19 2004-05-18
US Biogen Inc (BIIB)
S Sale
18,509 +41.8%
316.70
US$4,476,272 		18,509 +41.8% 316.70 US$4,476,272